Has Michael Bard, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,937 in general payments to Michael Bard, MD across 76 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Michael Bard, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Michael Bard, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Michael Bard, MD

Otolaryngology · Danbury, CTNPI 1255336616

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,625 of the $1,937 with a category attached, or 83.9%. 19 manufacturers reported payments, led by Inspire Medical Systems, Inc. at 28.7% of the total. 2025 is the largest year on record at $644, more than ten times the $44 reported in 2019. That places this record below the midpoint for otolaryngology clinicians in CT, where the typical reported total is $1,784.

$1,937in general payments, 2019–2025

Across 76 payments — averaging $25.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Inspire Medical Systems, Inc.$556
GSK$385
Checkpoint Surgical, Inc$159
Endo USA, Inc.$156
Regeneron Healthcare Solutions, Inc.$128
Stryker$79
plus $473 from 13 others

What the payments were for

Travel & lodging$31216%
Food & beverage$1,62584%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Inspire Medical Systems, Inc.	8	$556
GSK	29	$385
Checkpoint Surgical, Inc	2	$159
Endo USA, Inc.	8	$156
Regeneron Healthcare Solutions, Inc.	6	$128
Stryker	2	$79
Smith+Nephew	3	$78
Optinose US, Inc.	3	$71
Incyte Corporation	2	$53
AbbVie	2	$51
Amgen	2	$42
Hikma Pharmaceuticals USA	2	$29
Musculoskeletal Transplant Foundation Inc.	1	$26
Medtronic	1	$25
Merck	1	$24
Phathom Pharmaceuticals, Inc.	1	$20
Sanofi	1	$19
Solventum Corporation	1	$18
Integra Lifesciences Corporation	1	$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Inspire Upper Airway Stimulation System$312

How this compares

$1,937 in reported general payments places this provider in the 50th percentile of 119 otolaryngology providers in Connecticut.

See all otolaryngology providers in Connecticut →

Medicare billing

Part B allowed, 2024

$222,250

Medicare patients

841

Services billed

2,393

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth	53	$5,625
Fluticasone Propionate	156	$1,920
Ipratropium Bromide	107	$1,675
Famotidine	96	$1,028
Clotrimazole	25	$558
Mometasone Furoate	47	$510
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav	41	$436
Methylprednisolone	30	$233
Ofloxacin	18	$221
Prednisone	52	$183
Cefadroxil	18	$125
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	15	$59
Montelukast Sodium	15	$45
Azithromycin	12	$26

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Danbury

Dov BlochDanbury$7K
Jay KlarsfeldDanbury$4K
Michael DrobbinDanbury$3K
Danielle WarnerDanbury$3K
Mark DelacureDanbury$2K
Sara PaiNew Haven$160K
Richard ManesNew Haven$67K
Howard StupakWestport$48K
Belachew TessemaFarmington$45K
Seth BrownFarmington$39K

See the full list for Connecticut →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →